Acute #eGFR Changes With #Finerenone Examined in a Prespecified Analysis of #FINEONE
#VisualAbstract by Cristina Popa
https://www.kireports.org/article/S2468-0249(26)03315-2/fulltext
#VisualAbstract by Cristina Popa
https://www.kireports.org/article/S2468-0249(26)03315-2/fulltext
October 5, 2026 at 1:00 PM
Acute #eGFR Changes With #Finerenone Examined in a Prespecified Analysis of #FINEONE
#VisualAbstract by Cristina Popa
https://www.kireports.org/article/S2468-0249(26)03315-2/fulltext
#VisualAbstract by Cristina Popa
https://www.kireports.org/article/S2468-0249(26)03315-2/fulltext
CKD is common in #T1D and rises with age (∼30% at 40–59; >50% ≥60). Despite RASi, advances have been limited; SGLT2i/GLP-1RA aren’t advised in T1D. Finerenone blocks MR & lowers UACR potential bridge to kidney benefit. Watching #FINEONE to fill the cardio-renal gap. #KidneyWk
November 6, 2025 at 3:04 PM
Feed: "Blog - NephJC"
By: Brian Rifkin on Tuesday, May 5, 2026
By: Brian Rifkin on Tuesday, May 5, 2026
NephJC Short: Finerenone in Type I Diabetic CKD - Fine, but doesn’t reach the Finish Line? FINEONE
In type 1 diabetes is finerenone helpful to reduce proteinuria?
www.nephjc.com
May 5, 2026 at 10:45 PM
Feed: "Blog - NephJC"
By: Brian Rifkin on Tuesday, May 5, 2026
By: Brian Rifkin on Tuesday, May 5, 2026
🚨Another #NephJC short 🩳
FINE ONE: Finerenone in Type 1 Diabetes
Fine, but does it cross the finish line?
Blog by @nephromommy-akshu.bsky.social
#NephSky #MedSky
www.nephjc.com/news/2026/5/4/fineone
FINE ONE: Finerenone in Type 1 Diabetes
Fine, but does it cross the finish line?
Blog by @nephromommy-akshu.bsky.social
#NephSky #MedSky
www.nephjc.com/news/2026/5/4/fineone
NephJC Short: FINEONE — NephJC
In type 1 diabetes is finerenone helpful to reduce proteinuria?
www.nephjc.com
May 6, 2026 at 11:14 AM
🚨Another #NephJC short 🩳
FINE ONE: Finerenone in Type 1 Diabetes
Fine, but does it cross the finish line?
Blog by @nephromommy-akshu.bsky.social
#NephSky #MedSky
www.nephjc.com/news/2026/5/4/fineone
FINE ONE: Finerenone in Type 1 Diabetes
Fine, but does it cross the finish line?
Blog by @nephromommy-akshu.bsky.social
#NephSky #MedSky
www.nephjc.com/news/2026/5/4/fineone
T3p
What is the impact in pts with T1DM vs T2DM?
This study included T1D but did not report results separately.
FINEONE (nsMRA) study suggests similar pathology and benefits.
Should T1D get their own study?
#NephJC
What is the impact in pts with T1DM vs T2DM?
This study included T1D but did not report results separately.
FINEONE (nsMRA) study suggests similar pathology and benefits.
Should T1D get their own study?
#NephJC
March 11, 2026 at 1:49 AM
T3p
What is the impact in pts with T1DM vs T2DM?
This study included T1D but did not report results separately.
FINEONE (nsMRA) study suggests similar pathology and benefits.
Should T1D get their own study?
#NephJC
What is the impact in pts with T1DM vs T2DM?
This study included T1D but did not report results separately.
FINEONE (nsMRA) study suggests similar pathology and benefits.
Should T1D get their own study?
#NephJC
November 6, 2025 at 3:06 PM
Finally, FINEONE shows Finerenone
reduces albuminuria in T1DM
www.nejm.org/doi/full/10....
@nejm.org #NephSKy
reduces albuminuria in T1DM
www.nejm.org/doi/full/10....
@nejm.org #NephSKy
March 5, 2026 at 12:02 AM
Finally, FINEONE shows Finerenone
reduces albuminuria in T1DM
www.nejm.org/doi/full/10....
@nejm.org #NephSKy
reduces albuminuria in T1DM
www.nejm.org/doi/full/10....
@nejm.org #NephSKy
@captainchloride.bsky.social loves Cl 🤷♂️
@sophia-kidney.bsky.social makes a brilliant draft pick 🎣
@kidneyboy.bsky.social loves Tirzepatide
@brianrifkin.bsky.social likes FINEONE of course
#NephSky
@sophia-kidney.bsky.social makes a brilliant draft pick 🎣
@kidneyboy.bsky.social loves Tirzepatide
@brianrifkin.bsky.social likes FINEONE of course
#NephSky
November 19, 2025 at 2:38 PM
@captainchloride.bsky.social loves Cl 🤷♂️
@sophia-kidney.bsky.social makes a brilliant draft pick 🎣
@kidneyboy.bsky.social loves Tirzepatide
@brianrifkin.bsky.social likes FINEONE of course
#NephSky
@sophia-kidney.bsky.social makes a brilliant draft pick 🎣
@kidneyboy.bsky.social loves Tirzepatide
@brianrifkin.bsky.social likes FINEONE of course
#NephSky
Forgot to post the two at plenary on Thursday
FINEONE: finerenone in T1DM
ORIGIN: Atacicept (pronounced attack-e-sept) in IgAN (pronounced eye-gee-A-N)
Possible NEJM or Lancet simulpubs?
#KidneyWk
FINEONE: finerenone in T1DM
ORIGIN: Atacicept (pronounced attack-e-sept) in IgAN (pronounced eye-gee-A-N)
Possible NEJM or Lancet simulpubs?
#KidneyWk
November 5, 2025 at 7:17 PM
Forgot to post the two at plenary on Thursday
FINEONE: finerenone in T1DM
ORIGIN: Atacicept (pronounced attack-e-sept) in IgAN (pronounced eye-gee-A-N)
Possible NEJM or Lancet simulpubs?
#KidneyWk
FINEONE: finerenone in T1DM
ORIGIN: Atacicept (pronounced attack-e-sept) in IgAN (pronounced eye-gee-A-N)
Possible NEJM or Lancet simulpubs?
#KidneyWk
October 18, 2025 at 1:06 PM
Forgot to post the two at plenary on Thursday
FINEONE: finerenone in T1DM
ORIGIN: Atacicept (pronounced attack-e-sept) in IgAN (pronounced eye-gee-A-N)
Possible NEJM or Lancet simulpubs?
#KidneyWk
FINEONE: finerenone in T1DM
ORIGIN: Atacicept (pronounced attack-e-sept) in IgAN (pronounced eye-gee-A-N)
Possible NEJM or Lancet simulpubs?
#KidneyWk